Announcements Trials
Browse Landscape

Status

Completed 4

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 136Observational 4

Sponsor

Cancer Type

Breast 34Gastrointestinal 4Tumor-Agnostic 2CNS 2

Conditions

Stomach Neoplasms 4

Interventions

Blood Specimen Collection 87Surveys and Questionnaires 80Surgical Procedures, Operative 53Observation 44Drug Therapy 44Colonoscopy 41Bevacizumab 41Biopsy 35Hepatectomy 33Capecitabine 27Neoadjuvant Therapy 26Immune Checkpoint Inhibitors 26regorafenib 25Interviews as Topic 25Radiotherapy 24Oxaliplatin 24Sorafenib 22Magnetic Resonance Spectroscopy 22lenvatinib 21Endoscopic Mucosal Resection 21Specimen Handling 18Immunohistochemistry 18Endoscopy 18Pancreaticoduodenectomy 17Liquid Biopsy 17Gastrectomy 17Endoscopic Ultrasound-Guided Fine Needle Aspiration 17Tomography, X-Ray Computed 16Gastroscopy 16Fluorouracil 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × Trastuzumab × Gastrointestinal × Clear all
NCT07009600 2025-06-06

Conversion Surgery After Target Therapy or Immunotherapy in Stage IV Gastric Cancer

Samsung Medical Center

Completed
124 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01839500 2018-03-29

EVIDENCE

Hoffmann-La Roche

Completed
1,600 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03024450 2017-01-24

Trastuzumab Based Therapy in HER2 Positive AGC

Shanghai Zhongshan Hospital

Completed
98 enrolled
Gastrointestinal

Stomach Neoplasms

NCT02731313 2016-10-28

Human Epidermal Growth Factor Receptor 2 (HER-2) Status in Gastric and Gastro-Esophageal Junction (GEJ) Carcinoma

Hoffmann-La Roche

Completed
420 enrolled 8 charts
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡